Shares of Sanofi-Aventis SNY are lower on the session by 2.97%, currently trading at $37.25. The stock has been moving largely higher over the past five months and is currently trading above the 200-day moving average.
Options traders are buying calls on the name today. A short while ago the July 2011 $37.00 call was purchased 2,600 times, on the offer, on open interest of 12 contracts.
Overall call volume is now running at 3.39x the daily average with 99% of all calls traded being purchases on the offer.
Sanofi-Aventis is a pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. The company's business includes two main activities: pharmaceuticals and human vaccines through sanofi pasteur.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in